SS10: Late-Breaking Clinical Trials

Updated:Jan 9,2012
ss10_ginormous 


 
ss10_Tang
Anthony S. Tang
Ottawa, ON, Canada
RAFT
The Resynchronization/defibrillation for Ambulatory heart Failure Trial (RAFT)

Presentation slides  | Presentation audio
Play Audio
  |  Discussant slides 
Discussant audio
Play Audio
| Summary slide  |  News release
Video interview  |  Abstract
 

ss10_Aaronson
Keith D. Aaronson
University of Michigan
ADVANCE
Evaluation of the HeartWare® HVAD Left Ventricular Assist Device System for the Treatment of Advanced Heart Failure: Results of the ADVANCE Bridge to Transplant Trial.

Presentation slides  |  Presentation audio
Play Audio
  
Summary slide  |  News release 
Video interview  |  Abstract
 

ss10_Hernandez
Adrian F. Hernandez
 
Duke Clinical Research Institute
ASCEND-HF
Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF)

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide  |  News release 
Video interview  |  Abstract
 

ss10_Zannad
Faiez Zannad
University of Nancy
EMPHASIS-HF
The Effect Of Eplerenone Versus Placebo On Cardiovascular Mortality Or Heart Failure Hospitalization In Subjects With Nyha Class Ii Chronic Systolic Heart Failure. Emphasis-hf

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide  |  News release
Video interview  |  Abstract
 

ss10_LBCT02_Mahaffey
Kenneth Mahaffey
Duke University
ROCKET AF
Stroke Prevention Using the Oral Direct Factor Xa inhibitor Rivaroxaban Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation (ROCKET AF)

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides 
Discussant audio
Play Audio
| Summary slide  |  News release  
Video interview  |  Abstract
 

ss10_LBCT02_Ellenbogan
Kenneth A. Ellenbogen
Medical College of Virginia
SMART AV
Primary Results from the SMART AV Trial: A Randomized Trial Comparing Empiric, Echocardiographic Guided and Algorithmic AV Delay Programming in Cardiac Resynchronization Therapy (CRT)

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide  |  News release
Video interview   |  Article in Circulation |  Abstract 

ss10_LBCT02_Kowey
Peter R. Kowey
Lankenau Hospital
Fish Oil for AF
Efficacy And Safety Of Prescription Omega-3-Acid Ethyl Esters (P-OM3) For The Prevention Of Recurrent Symptomatic Atrial Fibrillation (AF)

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides  
Discussant audio 
Play Audio
Summary Slide  |  News release 
Video interview  | Article in JAMA |  Abstract
 

ss10_LBCT02_Furlan
Anthony Furlan
University Hospital
CLOSURE I
CLOSURE I: A Prospective, Multicenter, Randomized Controlled Trial to Evaluate the Safety and Efficacy of the STARFlex® Septal Closure System Versus Best Medical Therapy in Patients with a Stroke or Transient Ischemic Attack due to Presumed Paradoxical Embolism through a Patent Foramen Ovale

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide  |  News release
Video interview  |  Abstract
 

ss10_GRAVITAS
Matthew J. Price
Scripps Clinic
GRAVITAS
Standard Versus High-Dose Clopidogrel According to Platelet Function Testing After PCI: Results of the GRAVITAS Trial

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide  |  News release
Video interview  |  Abstract
 

ss10_TAMARIS
William R. Hiatt
University of Colorado Denver
TAMARIS
NV1FGF Gene Therapy on Amputation-Free Survival in Critical Limb Ischemia - Phase 3 Randomized Double-Blind Placebo-Controlled Trial

Presentation slides   |  Presentation audio
Play Audio
  |  Discussant slides  
Discussant audio
Play Audio
| Summary slide  |  News release  
Video interview  |  Abstract 

ss10_BASKET
Christoph A. Kaiser
University Hospital, Basel
BASKET PROVE
Late Cardiac Death And Myocardial Infarction Associated With Late Stent Thrombosis In Large Vessel Stenting After 1st Or 2nd Generation Drug-eluting Compared To Bare-metal Stents: the BASKET PROspective Evaluation Examination (BASKET PROVE)

Presentation slides   |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide   |  News release
Video interview  |  Article in NEJM |  Abstract 

ss10_ACT
Otavio Berwanger
Sao Paulo Cardiac Hospital
ACT
Acetylcystein for the Prevention of Contrast-Induced nephropaThy (ACT) Trial: a Pragmatic Multicenter Randomized Trial to Evaluate the Efficacy of Acetylcysteine for the Prevention of Renal Outcomes in Patients Undergoing Coronary and Vascular Angiography

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide  |  News release
Video interview  |  Abstract
 

ss10_LBCT04_Sever
Peter S. Sever
University of Glasgow
ASCOT
The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT): Testing C-Reactive Protein at baseline and on-treatment as an independent predictor of cardiovascular outcomes

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide  |  News release
Video interview  |  Abstract
 

ss10_LBCT04_Cannon
Christopher P. Cannon
TIMI Study Group
DEFINE
Primary Results of the DEFINE trial: Determining the EFficacy and Tolerability of CETP INhibition with AnacEtrapib

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide  |  News release
Video interview  |  Article in NEJM |  Abstract
 

ss10_LBCT04_Nicholls
Stephen J. Nicholls
Cleveland Clinic
The ASSERT Study
Results of the First Major Clinical Trial of An Oral Agent Inducing Apo A1 Synthesis: A New Approach to HDL Raising and CV Risk Modification

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide  |  News release
Video interview  |  Abstract 

ss10_LBCT04_Esler
Murray Esler
Baker IDI Heart and Diabetes Institute
Symplicity HTN-2
Symplicity HTN-2: International, Multicenter, Prospective, Randomized, Controlled Trial Of Endovascular Selective Renal Sympathetic Denervation For The Treatment Of Hypertension

Presentation slides  |  Presentation audio
Play Audio
  |  Discussant slides
Discussant audio
Play Audio
| Summary slide  |  News release
Video interview  |  Article in THE LANCET |  Abstract
 


 

Scientific Sessions

SS14-logo-dates-OSO

Scientific Sessions 2014
Scientific Sessions is the leading cardiovascular meeting in the country with over 17,000 professionals attending annually, and over 22,000 total attendees, as reported by the Healthcare Convention and Exhibitor’s Association. 

Chicago, IL
Nov. 15–19, 2014